I perhaps agree that NCE might be an issue. But I don't think 1A would hold anything back. REDUCE-IT is a virtual guarantee, remember? So in that case, the 1A case is irrelevant cause REDUCE-IT will result in Anchor population approval anyway. REDUCE-IT makes 1A moot. And if REDUCE-IT isn't successful, 1A won't matter either cause they won't have anything to promote. Would they still promote ANCHOR data and Jelis after REDUCE-IT fails? I doubt that.
No BO offers is really quite disturbing if you think about it. Did JZ burn all bridges or something?
Yes, NCE could be a big reason, despite JZ's "it's much ado about nothing". EVen AZN would rather start up their own CVE trial as opposed to trying to acquire AMRN? Weird.
News 
Market Data 
Discover 
AI
